Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)

Alzheimer’s disease is an age-related, neurodegenerative disorder, characterized by cognitive impairment and restrictions in activities of daily living. This disease is the most common form of dementia with complex multifactorial pathological mechanisms. Many therapeutic approaches have been propose...

Full description

Bibliographic Details
Main Authors: Tomáš Siatka, Markéta Adamcová, Lubomír Opletal, Lucie Cahlíková, Daniel Jun, Martina Hrabinová, Jiří Kuneš, Jakub Chlebek
Format: Article
Language:English
Published: MDPI AG 2017-07-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/22/7/1181
id doaj-2dc14400728245b2928137ec59f4c886
record_format Article
spelling doaj-2dc14400728245b2928137ec59f4c8862020-11-24T21:34:42ZengMDPI AGMolecules1420-30492017-07-01227118110.3390/molecules22071181molecules22071181Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)Tomáš Siatka0Markéta Adamcová1Lubomír Opletal2Lucie Cahlíková3Daniel Jun4Martina Hrabinová5Jiří Kuneš6Jakub Chlebek7Department of Pharmacognosy, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech RepublicDepartment of Pharmaceutical Botany and Ecology, ADINACO Research Group, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech RepublicDepartment of Pharmaceutical Botany and Ecology, ADINACO Research Group, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech RepublicDepartment of Pharmaceutical Botany and Ecology, ADINACO Research Group, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech RepublicDepartment of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Třebešská 1575, 500 01 Hradec Králové, Czech RepublicDepartment of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Třebešská 1575, 500 01 Hradec Králové, Czech RepublicDepartment of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech RepublicDepartment of Pharmaceutical Botany and Ecology, ADINACO Research Group, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech RepublicAlzheimer’s disease is an age-related, neurodegenerative disorder, characterized by cognitive impairment and restrictions in activities of daily living. This disease is the most common form of dementia with complex multifactorial pathological mechanisms. Many therapeutic approaches have been proposed. Among them, inhibition of acetylcholinesterase, butyrylcholinesterase, and prolyl oligopeptidase can be beneficial targets in the treatment of Alzheimer’s disease. Roots, along with aerial parts of Argemone platyceras, were extracted with ethanol and fractionated on an alumina column using light petrol, chloroform and ethanol. Subsequently, repeated preparative thin-layer chromatography led to the isolation of (+)-laudanosine, protopine, (–)-argemonine, allocryptopine, (–)-platycerine, (–)-munitagine, and (–)-norargemonine belonging to pavine, protopine and benzyltetrahydroisoquinoline structural types. Chemical structures of the isolated alkaloids were elucidated by optical rotation, spectroscopic and spectrometric analysis (NMR, MS), and comparison with literature data. (+)-Laudanosine was isolated from A. platyceras for the first time. Isolated compounds were tested for human blood acetylcholinesterase, human plasma butyrylcholinesterase and recombinant prolyl oligopeptidase inhibitory activity. The alkaloids inhibited the enzymes in a dose-dependent manner. The most active compound (–)-munitagine, a pavine alkaloid, inhibited both acetylcholinesterase and prolyl oligopeptidase with IC50 values of 62.3 ± 5.8 µM and 277.0 ± 31.3 µM, respectively.https://www.mdpi.com/1420-3049/22/7/1181Argemone platycerasalkaloidsacetylcholinesterasebutyrylcholinesteraseprolyl oligopeptidaseAlzheimer’s disease
collection DOAJ
language English
format Article
sources DOAJ
author Tomáš Siatka
Markéta Adamcová
Lubomír Opletal
Lucie Cahlíková
Daniel Jun
Martina Hrabinová
Jiří Kuneš
Jakub Chlebek
spellingShingle Tomáš Siatka
Markéta Adamcová
Lubomír Opletal
Lucie Cahlíková
Daniel Jun
Martina Hrabinová
Jiří Kuneš
Jakub Chlebek
Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)
Molecules
Argemone platyceras
alkaloids
acetylcholinesterase
butyrylcholinesterase
prolyl oligopeptidase
Alzheimer’s disease
author_facet Tomáš Siatka
Markéta Adamcová
Lubomír Opletal
Lucie Cahlíková
Daniel Jun
Martina Hrabinová
Jiří Kuneš
Jakub Chlebek
author_sort Tomáš Siatka
title Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)
title_short Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)
title_full Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)
title_fullStr Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)
title_full_unstemmed Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)
title_sort cholinesterase and prolyl oligopeptidase inhibitory activities of alkaloids from argemone platyceras (papaveraceae)
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2017-07-01
description Alzheimer’s disease is an age-related, neurodegenerative disorder, characterized by cognitive impairment and restrictions in activities of daily living. This disease is the most common form of dementia with complex multifactorial pathological mechanisms. Many therapeutic approaches have been proposed. Among them, inhibition of acetylcholinesterase, butyrylcholinesterase, and prolyl oligopeptidase can be beneficial targets in the treatment of Alzheimer’s disease. Roots, along with aerial parts of Argemone platyceras, were extracted with ethanol and fractionated on an alumina column using light petrol, chloroform and ethanol. Subsequently, repeated preparative thin-layer chromatography led to the isolation of (+)-laudanosine, protopine, (–)-argemonine, allocryptopine, (–)-platycerine, (–)-munitagine, and (–)-norargemonine belonging to pavine, protopine and benzyltetrahydroisoquinoline structural types. Chemical structures of the isolated alkaloids were elucidated by optical rotation, spectroscopic and spectrometric analysis (NMR, MS), and comparison with literature data. (+)-Laudanosine was isolated from A. platyceras for the first time. Isolated compounds were tested for human blood acetylcholinesterase, human plasma butyrylcholinesterase and recombinant prolyl oligopeptidase inhibitory activity. The alkaloids inhibited the enzymes in a dose-dependent manner. The most active compound (–)-munitagine, a pavine alkaloid, inhibited both acetylcholinesterase and prolyl oligopeptidase with IC50 values of 62.3 ± 5.8 µM and 277.0 ± 31.3 µM, respectively.
topic Argemone platyceras
alkaloids
acetylcholinesterase
butyrylcholinesterase
prolyl oligopeptidase
Alzheimer’s disease
url https://www.mdpi.com/1420-3049/22/7/1181
work_keys_str_mv AT tomassiatka cholinesteraseandprolyloligopeptidaseinhibitoryactivitiesofalkaloidsfromargemoneplatyceraspapaveraceae
AT marketaadamcova cholinesteraseandprolyloligopeptidaseinhibitoryactivitiesofalkaloidsfromargemoneplatyceraspapaveraceae
AT lubomiropletal cholinesteraseandprolyloligopeptidaseinhibitoryactivitiesofalkaloidsfromargemoneplatyceraspapaveraceae
AT luciecahlikova cholinesteraseandprolyloligopeptidaseinhibitoryactivitiesofalkaloidsfromargemoneplatyceraspapaveraceae
AT danieljun cholinesteraseandprolyloligopeptidaseinhibitoryactivitiesofalkaloidsfromargemoneplatyceraspapaveraceae
AT martinahrabinova cholinesteraseandprolyloligopeptidaseinhibitoryactivitiesofalkaloidsfromargemoneplatyceraspapaveraceae
AT jirikunes cholinesteraseandprolyloligopeptidaseinhibitoryactivitiesofalkaloidsfromargemoneplatyceraspapaveraceae
AT jakubchlebek cholinesteraseandprolyloligopeptidaseinhibitoryactivitiesofalkaloidsfromargemoneplatyceraspapaveraceae
_version_ 1725947897769361408